Alessia Anastasia
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model.
Journal: Journal of biomedical science
Published: May 20, 2025
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models.
Journal: Molecular oncology
Published: July 23, 2024
Charcot-Marie-Tooth type 2A in vivo models: Current updates.
Journal: Journal of cellular and molecular medicine
Published: January 16, 2024
Charcot-Marie-tooth disease type 2A: An update on pathogenesis and therapeutic perspectives.
Journal: Neurobiology of disease
Published: January 03, 2024
Combined RNA interference and gene replacement therapy targeting MFN2 as proof of principle for the treatment of Charcot-Marie-Tooth type 2A.
Journal: Cellular and molecular life sciences : CMLS
Published: April 14, 2023
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.
Journal: Journal of hematology & oncology
Published: August 04, 2021
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.
Journal: Molecular cancer therapeutics
Published: May 10, 2021
Soluble stroma-related biomarkers of pancreatic cancer.
Journal: EMBO molecular medicine
Published: June 27, 2018
Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.
Journal: Scientific reports
Published: August 09, 2017
Tph2 gene deletion enhances amphetamine-induced hypermotility: effect of 5-HT restoration and role of striatal noradrenaline release.
Journal: Journal of neurochemistry
Published: May 18, 2015
Last Updated: 09/26/2026